Trial Profile
Multicentre, randomised, double-blind, parallel-group, placebo-controlled clinical trial, comparing nateglinide versus placebo to assess the efficacy and tolerability of nateglinide in patients with type two diabetes mellitus.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Oct 2009
Price :
$35
*
At a glance
- Drugs Nateglinide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novartis
- 26 Apr 2007 New trial record.